🚀 VC round data is live in beta, check it out!
Fermentalg Valuation Multiples
Discover revenue and EBITDA valuation multiples for Fermentalg and similar public comparables like American Vanguard, Amoeba, Eden Research, Bioceres and more.
Fermentalg Overview
About Fermentalg
Fermentalg SA is an industrial biotechnology company engaged in producing natural cooking oils, animal nutrition products and chemicals using micro-algae.
Founded
2009
HQ
Employees
60
Website
Financials (LTM)
EV
$60M
Fermentalg Financials
Fermentalg reported last 12-month revenue of $18M and negative EBITDA of ($7M).
In the same LTM period, Fermentalg generated ($7M) in EBITDA losses and had net loss of ($10M).
Revenue (LTM)
Fermentalg P&L
In the most recent fiscal year, Fermentalg reported revenue of $14M and EBITDA of ($12M).
Fermentalg expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | $18M | XXX | $14M | XXX | XXX | XXX |
| Gross Profit | — | XXX | $3M | XXX | XXX | XXX |
| Gross Margin | — | XXX | 22% | XXX | XXX | XXX |
| EBITDA | ($7M) | XXX | ($12M) | XXX | XXX | XXX |
| EBITDA Margin | (37%) | XXX | (87%) | XXX | XXX | XXX |
| EBIT Margin | (57%) | XXX | (80%) | XXX | XXX | XXX |
| Net Profit | ($10M) | XXX | ($15M) | XXX | XXX | XXX |
| Net Margin | (57%) | XXX | (112%) | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Fermentalg Stock Performance
Fermentalg has current market cap of $64M, and enterprise value of $60M.
Market Cap Evolution
Fermentalg's stock price is $0.66.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $60M | $64M | 5.2% | XXX | XXX | XXX | $-0.16 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialFermentalg Valuation Multiples
Fermentalg trades at 3.4x EV/Revenue multiple, and (9.0x) EV/EBITDA.
EV / Revenue (LTM)
Fermentalg Financial Valuation Multiples
As of April 18, 2026, Fermentalg has market cap of $64M and EV of $60M.
Equity research analysts estimate Fermentalg's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Fermentalg has a P/E ratio of (6.2x).
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $64M | XXX | $64M | XXX | XXX | XXX |
| EV (current) | $60M | XXX | $60M | XXX | XXX | XXX |
| EV/Revenue | 3.4x | XXX | 4.4x | XXX | XXX | XXX |
| EV/EBITDA | (9.0x) | XXX | (5.1x) | XXX | XXX | XXX |
| EV/EBIT | (5.9x) | XXX | (5.5x) | XXX | XXX | XXX |
| EV/Gross Profit | — | XXX | 20.3x | XXX | XXX | XXX |
| P/E | (6.2x) | XXX | (4.2x) | XXX | XXX | XXX |
| EV/FCF | (6.7x) | XXX | (25.3x) | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Fermentalg Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Fermentalg Margins & Growth Rates
Fermentalg's revenue in the last 12 month grew by 57%.
Fermentalg's revenue per employee in the last FY averaged $0.2M, while opex per employee averaged $0.2M for the same period.
Fermentalg's rule of 40 is 32% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Fermentalg's rule of X is 107% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Fermentalg Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 57% | XXX | 14% | XXX | XXX | XXX |
| EBITDA Margin | (37%) | XXX | (87%) | XXX | XXX | XXX |
| EBITDA Growth | (53%) | XXX | (36%) | XXX | XXX | XXX |
| Rule of 40 | — | XXX | 32% | XXX | XXX | XXX |
| Bessemer Rule of X | — | XXX | 107% | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.2M | XXX | XXX | XXX |
| Opex per Employee | — | XXX | $0.2M | XXX | XXX | XXX |
| R&D Expenses to Revenue | 35% | XXX | 32% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 102% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Fermentalg Public Comps
See public comps and valuation multiples for other Bioindustrials comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Fermentalg | XXX | XXX | XXX | XXX | XXX | XXX |
| American Vanguard | XXX | XXX | XXX | XXX | XXX | XXX |
| Amoeba | XXX | XXX | XXX | XXX | XXX | XXX |
| Eden Research | XXX | XXX | XXX | XXX | XXX | XXX |
| Bioceres | XXX | XXX | XXX | XXX | XXX | XXX |
| Dyadic | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Fermentalg M&A Activity
Fermentalg acquired XXX companies to date.
Last acquisition by Fermentalg was on XXXXXXXX, XXXXX. Fermentalg acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Fermentalg
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialFermentalg Investment Activity
Fermentalg invested in XXX companies to date.
Fermentalg made its latest investment on XXXXXXXX, XXXXX. Fermentalg invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Fermentalg
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Fermentalg
| When was Fermentalg founded? | Fermentalg was founded in 2009. |
| Where is Fermentalg headquartered? | Fermentalg is headquartered in France. |
| How many employees does Fermentalg have? | As of today, Fermentalg has over 60 employees. |
| Is Fermentalg publicly listed? | Yes, Fermentalg is a public company listed on Euronext Paris. |
| What is the stock symbol of Fermentalg? | Fermentalg trades under ALGAE ticker. |
| When did Fermentalg go public? | Fermentalg went public in 2014. |
| Who are competitors of Fermentalg? | Fermentalg main competitors are American Vanguard, Amoeba, Eden Research, Bioceres. |
| What is the current market cap of Fermentalg? | Fermentalg's current market cap is $64M. |
| What is the current revenue of Fermentalg? | Fermentalg's last 12 months revenue is $18M. |
| What is the current revenue growth of Fermentalg? | Fermentalg revenue growth (NTM/LTM) is 57%. |
| What is the current EV/Revenue multiple of Fermentalg? | Current revenue multiple of Fermentalg is 3.4x. |
| Is Fermentalg profitable? | No, Fermentalg is not profitable. |
| What is the current EBITDA of Fermentalg? | Fermentalg has negative EBITDA and is not profitable. |
| What is Fermentalg's EBITDA margin? | Fermentalg's last 12 months EBITDA margin is (37%). |
| What is the current EV/EBITDA multiple of Fermentalg? | Current EBITDA multiple of Fermentalg is (9.0x). |
| What is the current FCF of Fermentalg? | Fermentalg's last 12 months FCF is ($9M). |
| What is Fermentalg's FCF margin? | Fermentalg's last 12 months FCF margin is (50%). |
| What is the current EV/FCF multiple of Fermentalg? | Current FCF multiple of Fermentalg is (6.7x). |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.